Harlan beefs up Israeli offering; Novartis looks to outsource data management;

> Harlan Laboratories has expanded its Israeli operation to include disease-preconditioned animal model and imaging services. News

> Novartis ($NVS) is looking to cut costs by outsourcing more of its data management services. Article

> Quintiles ($Q) won best CRO for the second year in a row at the annual Scrip Awards. More

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.